This content is machine translated Urothelial carcinoma Immune and targeted therapy options: Evidence situation 2025/2026 The treatment of urothelial carcinoma has developed significantly in recent years. Modern immunotherapies, antibody-drug conjugates (ADCs) and targeted substances complement conventional chemotherapies and increasingly enable individualized treatment strategies. New data...…
View Post 4 min This content is machine translated Cutaneous squamous cell carcinoma A dermato-oncological challenge in advanced stages The treatment options for locally advanced and metastatic forms of cutaneous squamous cell carcinoma (cSCC) have improved considerably thanks to immunotherapy with PD-1 inhibitors, as several clinical studies have impressively…
